rfhg_236890.1

Basic information about the TSS

---

TSS ID: rfhg_236890.1 Species: human Chr: chrX		Start: 71300490 End: 71300517 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: L32558:213 GeneID: 4841 HGNC/MGI_ID: HGNC:7871 UniProt_ID: Q15559 Nearer transcript ids and distances:

Gene_name: non-POU domain containing octamer binding Gene_symbol: NONO Gene_synonyms: NMT55 NRB54 P54 P54NRB PPP1R114 Gene_source: HGNC:7871

TATA-Box annotation

---

Distance to TSS:	-1247
Nearest PromoterID:	NM_012278
Entrez ID:	26548
Nearest Unigene:	Hs.109999
Nearest Refseq:	NM_012278
Nearest Ensembl:	ENSG00000147166
Gene Name:	non-POU domain containing octamer binding
Gene Alias:	CHORDC3|ITGB1BP|MELUSIN|MSTP015
Gene Type:	protein-coding
CpG%:	0.037037
GC%:	0.571429
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NONO p2@NONO p3@NONO p4@NONO
Sample		p1@NONO	p2@NONO	p3@NONO	p4@NONO
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	142.79	28.05	0.78	2.92
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	133.33	28.12	1.42	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	144.87	26.81	1.93	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	133.89	24.12	2.29	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	122.61	26.55	1.12	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	131.21	22.68	1.74	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	145.55	26.36	1.74	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	154.05	34.15	1.21	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	142.98	35.69	0.85	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	108.39	20.29	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	101.46	22.23	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	112.62	28.46	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	74.47	3.06	0.16	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	65.25	3.76	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	79.70	3.07	0.44	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	66.64	1.76	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	65.09	3.93	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	59.48	2.53	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	62.91	5.86	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	80.94	3.61	0.15	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	62.95	3.07	0.40	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	71.81	2.93	0.52	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.85	4.65	0.13	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	60.18	4.13	0.24	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	66.05	5.68	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	71.85	4.75	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	66.48	4.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	74.03	8.02	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	64.12	2.58	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	62.98	4.52	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	64.27	3.56	0.63	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	67.80	5.28	0.39	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	58.03	4.22	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	85.27	5.94	0.16	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	79.28	3.74	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	63.24	4.02	0.00	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	69.28	6.13	1.02	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.68	3.83	0.60	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	63.20	6.21	0.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	76.82	6.72	0.72	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	59.29	5.41	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	78.76	3.22	0.29	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	81.19	6.54	0.42	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	72.73	5.24	0.35	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	83.52	6.63	0.60	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	77.70	10.24	0.47	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	67.17	6.00	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	90.31	9.54	0.30	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	71.33	8.38	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	98.67	8.29	0.20	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	87.52	9.63	0.41	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	92.95	7.56	0.89	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	251.86	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	73.46	7.81	0.71	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	65.95	8.95	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	182.05	29.36	0.84	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	124.91	15.61	0.92	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	57.04	6.16	1.30	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	53.96	2.89	0.64	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	149.31	13.52	1.26	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	61.34	7.76	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	62.25	3.93	0.56	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	230.09	21.50	0.80	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	123.68	12.23	0.34	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	60.44	7.47	1.62	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.73	5.32	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	39.49	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.46	3.90	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	54.55	2.98	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.50	4.69	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	66.57	7.29	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	43.00	2.47	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.66	2.45	0.31	1.53
Adipocyte - breast, donor1	11376-118A8	46.72	2.85	1.27	0.48
Adipocyte - breast, donor2	11327-117E4	35.29	1.76	0.16	2.73
Adipocyte - omental, donor1	11473-119C6	46.31	4.71	1.27	0.25
Adipocyte - omental, donor2	11474-119C7	39.62	5.23	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	33.49	5.36	1.34	1.34
Adipocyte - perirenal, donor1	11476-119C9	29.99	6.38	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	25.29	9.90	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	57.36	8.58	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	40.32	2.61	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	84.68	2.93	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	51.48	1.29	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	40.70	1.67	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	45.85	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	58.56	3.94	0.64	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	44.54	1.61	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	34.12	3.20	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	25.60	3.34	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.86	6.24	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.89	1.51	0.25	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	35.34	0.98	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	30.45	2.44	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	73.59	6.41	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	38.73	6.45	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	26.36	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	81.14	5.22	0.72	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	3.35	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	56.91	2.47	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	77.70	3.78	0.69	0.57
Anulus Pulposus Cell, donor2	11463-119B5	52.41	6.12	0.00	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	60.21	6.74	1.80	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	71.63	7.38	1.30	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	8.56	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	69.05	6.28	0.30	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	77.14	10.12	3.79	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	48.85	2.64	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	63.35	8.12	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	67.48	5.34	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	43.95	3.56	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	73.82	12.43	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	73.29	10.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	42.63	6.27	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	58.65	4.12	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	98.27	15.01	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	50.21	3.32	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	68.58	7.50	0.00	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	60.46	5.67	1.70	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.90	6.15	1.87	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	69.26	11.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	64.85	8.46	1.00	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	106.20	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.63	5.32	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	79.61	6.31	1.46	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	78.55	8.35	0.38	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	44.82	9.69	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	79.80	9.12	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	56.01	2.99	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	46.46	2.84	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	65.22	4.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	51.77	4.50	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	48.51	2.85	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	60.25	4.68	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	54.80	5.42	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	48.71	2.38	7.13	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	67.64	9.15	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	65.45	5.60	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	37.49	4.45	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	57.39	4.75	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	63.72	7.20	1.27	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.12	3.19	1.45	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	70.86	9.45	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	59.84	4.41	0.85	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	107.74	19.01	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	63.68	5.57	1.07	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	40.91	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	70.71	6.56	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	68.04	5.75	0.92	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	45.76	5.85	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	65.44	6.19	1.45	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.90	4.28	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	71.70	9.08	1.43	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	62.53	5.99	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	44.25	4.58	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	54.28	4.43	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	64.61	4.77	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	44.70	3.63	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	124.29	17.56	1.11	0.61
Astrocyte - cerebellum, donor2	11580-120F5	75.65	15.58	0.00	1.03
Astrocyte - cerebellum, donor3	11661-122F5	53.07	4.40	0.00	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	160.35	16.03	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	126.51	10.03	0.32	2.26
Astrocyte - cerebral cortex, donor3	11392-118C6	120.97	11.63	0.60	2.68
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	139.80	6.65	1.38	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	152.97	8.14	1.25	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	132.46	6.26	1.25	2.16
Basophils, donor1	12241-129G9	69.57	5.49	0.26	0.00
Basophils, donor2	12242-129H1	115.09	7.94	1.44	0.36
Basophils, donor3	12243-129H2	83.49	5.88	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	41.40	3.23	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	13.72	1.37	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	59.63	15.06	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	64.05	15.80	0.21	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	42.37	5.99	0.69	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	43.55	3.78	0.54	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	166.33	13.60	0.93	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	142.30	10.01	0.00	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	123.43	14.39	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	78.33	10.71	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	90.76	6.87	0.37	1.11
CD14+ Monocytes, donor3	11381-118B4	90.01	8.12	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	68.21	2.55	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.93	0.76	1.14	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	58.84	1.64	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	71.41	5.06	1.01	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	76.94	5.13	2.41	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	77.94	6.87	0.95	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	68.97	5.52	1.17	1.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	56.58	4.97	2.21	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	74.13	7.69	1.98	1.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	63.64	5.29	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	69.08	7.66	0.53	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	89.01	5.66	0.87	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	66.02	4.45	0.23	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	79.20	7.92	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	78.76	5.55	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	67.38	4.46	0.74	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	62.46	7.38	0.20	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	82.24	8.54	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	87.17	5.49	1.14	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	76.00	3.17	1.36	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	85.55	10.48	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	56.22	2.96	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	91.42	4.36	1.05	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	87.11	10.52	2.95	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	74.95	4.96	0.55	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	75.03	5.99	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	95.64	9.65	0.88	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	53.36	2.62	0.70	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	60.95	5.20	0.00	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	98.94	7.33	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	73.30	4.09	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	76.03	4.87	1.85	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	77.49	7.42	0.46	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	80.65	4.58	0.44	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	77.61	8.32	0.92	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	75.38	4.98	1.30	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	89.38	4.98	0.93	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	86.80	4.54	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	121.30	5.80	1.11	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	61.24	4.85	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	80.80	5.71	0.44	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	74.53	3.58	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	95.52	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	111.87	3.39	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	109.77	5.18	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	89.02	5.86	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	140.45	2.14	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	110.91	2.11	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	4.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	114.69	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	158.63	7.40	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	143.63	8.71	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	144.89	10.60	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	110.31	14.14	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	83.89	9.19	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	85.34	7.03	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	139.33	18.54	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	159.32	18.04	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	149.72	22.55	2.48	1.35
CD4+ T Cells, donor1	11225-116C1	226.37	27.14	1.43	1.07
CD4+ T Cells, donor2	11306-117C1	137.17	8.57	0.61	3.06
CD4+ T Cells, donor3	11382-118B5	124.44	16.16	0.61	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	117.92	4.59	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	112.52	3.82	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	110.38	2.87	1.15	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	158.35	7.11	0.95	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	187.52	9.13	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	138.44	6.59	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	102.03	7.51	1.16	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.92	4.41	1.02	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	73.83	3.39	0.16	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	122.39	8.07	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	127.53	5.94	0.70	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	145.19	11.00	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	116.37	15.18	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	87.06	3.53	0.42	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	68.83	5.68	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	156.09	6.80	1.63	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	241.18	8.58	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	179.32	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	132.02	9.83	0.93	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	97.48	7.15	0.65	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	116.00	6.30	1.05	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	117.81	8.09	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	117.41	9.53	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	182.17	15.69	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	151.92	2.47	0.49	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	148.63	5.54	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	160.52	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	176.96	3.60	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	219.38	5.64	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	133.98	4.62	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	158.29	5.37	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	132.96	4.15	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	166.32	19.97	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	132.15	15.02	1.88	1.13
CD8+ T Cells, donor3	11383-118B6	154.78	22.72	1.51	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	83.73	9.18	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	83.16	9.83	0.24	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	90.29	8.75	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	132.09	22.52	0.90	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	73.19	12.48	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	81.63	7.96	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	92.78	14.78	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	82.38	12.11	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	89.35	14.77	0.23	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	87.54	9.96	1.21	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	68.85	8.13	0.00	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	86.06	15.45	0.00	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	80.11	13.13	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	74.69	12.75	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	91.00	9.70	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	87.16	8.64	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	86.89	6.04	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	65.52	5.42	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	103.31	16.80	0.00	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	93.19	11.38	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	97.78	13.46	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	97.15	15.30	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	71.73	9.06	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	64.30	14.37	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.92	13.65	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	80.43	13.99	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	92.16	16.03	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	54.83	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	65.22	4.45	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	61.77	4.21	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	65.52	7.97	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	51.53	6.04	0.36	1.42
Chondrocyte - de diff, donor3	11410-118E6	43.35	1.48	0.34	0.46
Chondrocyte - re diff, donor2	11339-117F7	155.77	25.07	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	36.40	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	134.61	10.67	0.92	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	77.60	5.56	0.64	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	94.96	6.28	0.53	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	84.55	3.30	2.29	0.55
Corneal Epithelial Cells, donor1	11526-119I5	39.74	3.51	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	39.82	11.38	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	38.09	4.35	0.26	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	48.54	3.47	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	52.36	5.05	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.17	4.00	0.00	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	116.84	9.22	2.73	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	130.57	12.40	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	124.86	4.36	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	108.40	13.51	1.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	76.87	8.21	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	72.68	7.92	1.70	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	60.16	3.15	1.97	0.79
Endothelial Cells - Artery, donor1	11264-116G4	65.16	11.05	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	80.94	11.06	1.65	1.65
Endothelial Cells - Artery, donor3	11413-118E9	100.98	9.99	1.05	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	81.35	7.09	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	71.81	9.13	1.83	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	89.08	10.99	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	73.99	12.18	0.30	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	51.55	4.69	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	45.94	3.54	0.71	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	134.84	18.01	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	45.60	8.91	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	136.30	16.65	1.12	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	89.29	9.56	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	88.91	10.26	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	79.63	17.06	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	81.72	12.57	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	56.21	9.58	0.31	0.31
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	108.92	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	85.60	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	33.47	1.71	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.93	6.57	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.18	3.61	1.09	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	33.04	3.79	0.76	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	70.58	10.07	1.09	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	91.30	14.74	1.09	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.97	2.85	0.63	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	100.65	21.34	0.79	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	67.44	8.30	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	62.60	8.17	0.45	1.36
Fibroblast - Cardiac, donor2	11345-117G4	59.12	7.58	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	36.43	2.68	0.32	0.95
Fibroblast - Cardiac, donor4	11452-119A3	75.47	9.09	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	54.44	6.47	0.38	0.38
Fibroblast - Cardiac, donor6	11460-119B2	69.28	9.55	0.45	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	77.31	6.30	1.21	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	64.28	3.45	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	83.49	4.39	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	78.19	4.38	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	73.44	1.19	0.34	0.68
Fibroblast - Dermal, donor1	11269-116G9	44.84	6.34	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	89.15	8.96	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	43.88	3.38	0.36	0.85
Fibroblast - Dermal, donor4	11450-119A1	83.88	12.77	0.34	1.24
Fibroblast - Dermal, donor5	11454-119A5	101.71	12.04	0.70	1.22
Fibroblast - Dermal, donor6	11458-119A9	114.18	15.43	0.49	1.46
Fibroblast - Gingival, donor1	11237-116D4	66.01	6.25	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	83.05	3.67	1.83	1.57
Fibroblast - Gingival, donor2	11318-117D4	102.00	8.04	0.40	1.58
Fibroblast - Gingival, donor3	11394-118C8	59.46	3.38	0.10	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	62.33	4.16	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.35	1.94	0.35	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	90.73	8.26	1.56	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	78.16	6.49	1.49	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	40.93	3.88	2.12	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	70.78	4.24	0.73	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	86.99	6.95	0.95	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	119.78	8.23	1.32	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.10	2.64	1.47	0.59
Fibroblast - Lung, donor1	11270-116H1	58.45	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	105.94	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	67.95	5.70	0.21	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	74.97	14.99	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	46.15	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	14.55	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	138.84	14.21	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	126.66	11.64	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	114.52	9.56	0.30	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	94.24	12.85	1.84	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	70.60	8.78	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.00	4.05	0.00	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	43.49	2.09	0.81	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	78.81	10.83	0.44	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	88.79	4.47	1.22	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	68.16	7.35	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.84	3.56	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	152.61	22.42	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	57.90	3.73	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	69.77	5.72	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	110.11	20.46	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	89.28	6.48	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	115.66	15.18	1.27	1.01
Fibroblast - skin normal, donor1	11553-120C5	60.38	4.92	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	147.17	20.05	0.60	0.40
Fibroblast - skin normal, donor2	11561-120D4	87.60	9.24	1.51	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	189.20	25.69	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	65.78	2.98	0.75	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	87.36	5.98	0.85	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	113.64	21.35	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	101.20	13.95	1.07	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	101.55	12.31	1.52	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	60.06	6.12	0.94	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	487.52	155.12	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	47.93	7.84	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	45.94	2.95	0.87	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	45.80	4.68	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	55.45	6.13	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	154.64	20.67	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	149.31	21.06	0.64	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	240.76	19.40	1.14	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	185.58	5.52	0.55	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	175.13	6.85	0.23	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	165.04	16.05	0.79	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	162.83	10.31	0.26	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	150.68	4.89	0.00	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	164.06	15.92	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	178.49	7.07	0.28	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	156.51	5.91	0.00	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	128.40	12.63	0.00	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	132.32	4.83	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	145.49	5.26	0.00	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	102.87	7.12	0.20	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	95.84	4.34	0.00	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	128.18	3.74	0.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	96.83	4.81	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	109.62	5.02	0.30	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	145.76	5.25	0.00	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	96.74	4.24	0.22	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	111.91	5.65	0.60	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	165.40	6.11	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	133.63	7.27	0.35	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	171.38	6.66	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	165.48	4.95	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	155.80	3.21	0.55	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	125.88	5.66	0.33	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	136.19	7.55	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	118.01	5.98	0.21	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	153.22	2.42	0.35	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	106.06	3.34	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	92.14	4.41	0.00	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	155.09	3.81	0.12	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	93.53	5.35	0.00	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	101.99	2.25	0.00	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	120.72	2.37	0.28	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	74.50	3.64	0.32	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	104.30	5.78	0.30	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	121.47	4.81	0.31	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	74.87	3.51	0.44	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	91.18	3.37	0.00	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	124.34	4.91	0.83	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	69.79	4.01	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	100.52	5.36	0.31	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	100.00	3.76	0.26	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	81.32	4.34	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	88.86	7.01	0.55	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	78.95	3.29	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	121.98	6.94	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	83.37	5.67	0.40	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	71.42	1.82	0.61	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	178.17	8.64	1.27	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	248.63	21.50	0.00	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	184.28	7.55	0.15	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	259.41	11.05	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	151.77	15.96	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	127.72	9.61	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	155.89	13.37	0.46	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	7.42	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	152.02	9.67	0.39	2.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	137.98	14.44	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	133.89	17.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	123.68	12.37	0.98	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	133.42	8.24	0.00	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	139.96	13.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	125.84	8.39	0.28	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	125.51	9.48	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	133.38	5.03	0.00	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	118.00	7.00	0.32	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	127.03	6.11	0.34	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	112.76	8.35	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	148.33	9.74	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	116.32	4.44	0.30	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	101.65	6.78	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	141.66	8.70	0.00	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	154.65	11.05	0.23	2.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	109.94	5.38	0.38	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	106.92	3.26	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	67.55	2.01	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	109.42	1.93	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	153.71	9.24	0.00	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	0.00	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	125.04	4.25	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	87.51	1.81	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	115.98	4.07	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	145.58	7.18	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	124.82	1.48	0.00	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	131.03	11.80	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	101.52	5.83	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	116.74	1.32	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	94.09	5.09	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	93.12	5.37	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	89.29	3.88	0.00	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	55.92	6.85	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	37.42	4.57	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	51.72	4.50	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	40.91	5.71	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	32.17	2.51	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	108.38	19.38	1.86	1.97
Hep-2 cells mock treated, biol_rep2	11899-125E9	107.02	19.07	1.86	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	105.33	23.21	0.46	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	110.07	16.94	1.42	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	108.75	26.65	2.36	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	99.89	24.97	1.08	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	101.62	16.31	1.12	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	102.59	20.07	1.20	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	81.69	25.63	1.60	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	71.07	15.11	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	47.17	2.16	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	65.61	6.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	46.50	2.91	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	61.72	8.22	0.00	1.05
Hepatocyte, donor1	11523-119I2	64.16	7.26	1.21	0.00
Hepatocyte, donor2	11603-120I1	63.56	5.39	1.08	0.00
Hepatocyte, donor3	11684-122I1	57.67	5.52	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	187.97	35.90	0.00	5.87
Intestinal epithelial cells (polarized), donor1	11246-116E4	125.32	12.76	0.00	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	84.11	6.72	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	92.33	12.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	94.14	11.08	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	67.57	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	74.32	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	110.45	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	93.37	13.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	93.13	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	94.29	5.24	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	88.18	3.78	1.26	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	88.16	6.19	0.00	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	100.78	5.81	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	132.01	8.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	126.31	10.59	0.81	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	100.75	11.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	114.12	9.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	79.40	8.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	89.69	4.72	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	87.07	6.35	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	105.46	6.46	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	111.80	13.98	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	119.88	13.39	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	123.94	14.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	123.53	7.14	2.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	79.64	9.95	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	89.20	5.25	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	101.85	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	91.79	5.56	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	57.54	13.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	81.05	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	95.04	7.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	74.24	4.50	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	80.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	91.74	6.40	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	84.51	8.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	79.79	5.70	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	79.16	4.60	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	87.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	81.42	2.11	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	52.96	5.88	0.65	0.08
Keratinocyte - epidermal, donor2	11349-117G8	33.38	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	49.51	3.69	0.09	0.47
Keratinocyte - oral, donor1	11251-116E9	92.97	4.31	0.34	1.36
Keratocytes, donor1	11527-119I6	89.05	3.09	0.00	0.00
Keratocytes, donor2	11607-120I5	44.53	4.69	0.00	0.00
Keratocytes, donor3	11688-122I5	53.55	1.78	0.79	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	206.60	6.59	6.59	2.20
Lens Epithelial Cells, donor1	11529-119I8	71.20	9.71	0.00	3.24
Lens Epithelial Cells, donor2	11609-120I7	138.51	5.54	0.46	0.23
Lens Epithelial Cells, donor3	11690-122I7	97.48	5.75	0.61	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	79.80	7.23	0.24	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	50.51	4.47	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	66.90	4.41	0.47	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	56.46	6.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	57.04	2.52	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	69.65	5.82	0.22	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	53.76	5.34	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	51.58	6.07	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	60.94	6.19	0.42	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	44.30	4.75	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.53	5.04	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	49.62	3.52	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	49.13	5.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	54.38	4.53	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	58.51	5.22	0.27	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	45.89	4.93	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	43.33	4.68	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	66.61	4.94	0.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	51.01	6.91	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	47.15	4.39	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	71.94	5.48	0.25	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.86	6.30	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.82	5.92	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	64.34	5.90	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	49.77	4.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.67	3.14	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	64.81	4.66	0.45	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	58.47	7.57	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.33	3.95	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	63.51	5.51	0.21	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.61	4.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	38.37	2.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	65.66	4.34	0.12	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	58.86	7.40	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.50	3.46	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	58.57	4.95	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	59.50	4.50	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.78	3.35	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	62.00	4.90	0.98	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.51	4.27	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	42.18	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	57.57	4.82	0.16	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	61.59	5.73	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	46.39	2.94	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	55.80	4.94	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	79.20	4.70	0.37	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	35.60	3.59	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	70.71	9.55	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	70.25	18.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	75.18	16.88	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	82.39	13.36	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	73.20	12.27	0.85	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	75.26	14.77	1.41	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	79.39	8.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	75.74	14.43	1.03	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	88.02	8.33	2.38	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	75.10	9.95	1.13	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	72.13	9.02	1.45	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	82.83	14.86	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	98.90	10.16	1.49	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	76.52	8.73	1.54	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	85.04	14.82	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	88.62	9.99	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	69.79	13.75	2.04	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	88.85	13.34	1.33	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	101.65	8.12	0.94	3.21
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.65	12.88	2.45	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	106.82	26.09	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	97.67	10.62	1.46	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	79.03	17.66	0.84	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	79.34	14.42	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	96.09	8.71	2.03	3.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	72.64	17.34	1.20	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	89.07	11.62	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	103.57	7.07	0.71	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	72.65	15.12	1.11	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	74.83	12.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	85.19	7.29	0.38	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	71.90	11.32	2.26	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	91.89	18.05	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	82.24	7.23	2.26	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	61.76	10.77	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	72.45	11.95	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	85.84	9.29	0.74	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	58.15	13.35	1.72	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	97.62	10.28	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	84.63	9.00	1.67	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	75.41	17.50	1.81	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	71.10	15.64	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	89.37	7.91	1.37	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	73.53	16.10	0.54	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	74.74	10.77	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	94.08	7.78	0.74	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	50.01	6.98	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	52.89	14.81	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	110.44	7.60	0.00	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	62.51	13.08	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	85.85	12.26	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	96.68	12.83	1.48	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	48.93	11.29	1.88	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	78.94	11.06	2.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	94.63	5.86	1.35	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	65.40	15.49	0.00	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	103.76	12.02	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	86.03	8.60	1.56	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	64.65	13.85	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	96.52	15.05	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	101.52	11.38	2.63	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	78.27	12.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	93.63	11.04	0.88	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	104.14	9.26	0.39	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	68.36	15.19	2.03	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	85.07	10.09	0.96	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	93.03	11.13	1.99	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	59.55	12.76	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	78.85	19.37	1.38	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	109.44	13.30	0.76	3.80
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	74.88	12.39	0.52	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	88.88	19.95	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	106.16	7.92	1.90	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	70.37	9.60	3.20	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	83.90	16.67	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	121.36	8.74	1.54	4.63
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	69.32	7.07	1.41	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	93.64	18.16	2.27	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	91.94	10.82	0.42	4.16
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	8.61	3.92	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	88.52	17.12	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	82.71	8.83	0.93	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	62.89	8.70	2.68	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	103.19	17.11	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	81.63	8.49	1.21	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	66.08	11.93	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	94.25	15.11	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	79.78	12.54	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.98	11.50	2.30	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	98.49	16.96	0.55	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	69.94	11.58	1.34	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	85.27	10.92	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	88.86	22.55	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	99.77	10.39	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	47.86	2.51	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	50.28	6.42	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	41.16	3.01	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	37.70	4.25	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	71.30	5.39	1.11	0.16
Mallassez-derived cells, donor3	11930-125I4	73.66	8.20	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	53.01	3.69	0.40	0.30
Mammary Epithelial Cell, donor2	11350-117G9	63.12	6.08	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	51.88	2.99	0.25	0.75
Mast cell - stimulated, donor1	11487-119E2	302.36	25.76	4.75	2.03
Mast cell, donor1	11563-120D6	158.21	7.79	0.76	0.43
Mast cell, donor2	11565-120D8	161.37	7.13	1.49	1.19
Mast cell, donor3	11566-120D9	203.29	4.50	0.45	0.45
Mast cell, donor4	11567-120E1	126.05	7.27	1.06	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	154.92	3.66	0.78	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	93.97	3.50	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	140.76	4.13	1.03	1.26
Mast cell, expanded, donor8	11941-126A6	111.30	3.18	1.84	1.34
Melanocyte - dark, donor1	11502-119F8	81.29	8.66	0.30	0.20
Melanocyte - dark, donor2	11582-120F7	63.68	7.61	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	105.98	10.21	0.36	0.43
Melanocyte - light, donor1	11274-116H5	46.07	5.41	0.00	0.00
Melanocyte - light, donor2	11351-117H1	47.09	3.41	0.00	0.68
Melanocyte - light, donor3	11423-118G1	42.49	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	85.70	6.77	0.31	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	51.64	5.92	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	68.84	8.30	0.00	0.27
Meningeal Cells, donor1	11493-119E8	160.53	14.89	1.24	0.37
Meningeal Cells, donor2	11573-120E7	133.80	18.05	0.88	2.20
Meningeal Cells, donor3	11654-122E7	139.78	9.86	0.82	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	88.97	10.55	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	67.52	4.13	0.70	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	7.85	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	55.26	5.02	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	70.31	6.14	1.27	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	59.81	7.54	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	87.68	8.79	0.66	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	89.13	12.42	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	75.91	8.59	0.41	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	67.45	3.05	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	32.34	1.12	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.34	2.37	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	39.76	2.67	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	65.96	10.89	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	90.03	8.86	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	55.35	2.50	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	71.84	7.26	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	54.10	2.65	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	48.04	4.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	49.43	2.17	0.51	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	62.31	3.69	0.74	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	50.35	2.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.71	2.17	0.31	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	33.40	2.49	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	47.80	4.75	0.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	2.79	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.08	2.85	0.20	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.86	3.96	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	1.77	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	41.79	1.52	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	42.23	3.40	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	35.77	3.28	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	38.39	4.01	0.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	32.09	2.61	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	40.52	2.76	0.00	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	42.28	1.89	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.24	1.43	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	46.77	1.93	0.43	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.57	2.45	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.66	2.41	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	31.80	1.63	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	32.64	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	30.27	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.42	2.80	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	2.74	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	36.54	3.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	32.62	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	40.73	3.07	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	29.46	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	49.34	0.99	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.34	6.50	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.02	2.49	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.28	5.33	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	34.91	1.66	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.81	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	34.09	2.41	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	46.75	3.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	1.85	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	37.56	5.12	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	36.89	2.76	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	36.80	5.96	0.00	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	31.32	3.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.77	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.49	2.14	0.53	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	48.79	5.09	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	35.31	1.98	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	35.04	2.23	0.00	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.68	5.75	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	35.80	3.69	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	33.68	5.90	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	35.28	4.70	0.00	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	46.71	5.19	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	31.74	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	41.99	2.98	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	48.96	2.30	0.00	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.58	1.98	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.98	2.79	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	54.08	2.25	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	35.16	1.60	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.62	1.24	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	51.67	3.30	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.43	2.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	33.33	2.02	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.72	2.95	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	49.03	9.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	2.54	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.82	2.43	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	16.31	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	77.56	12.28	1.08	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.69	12.54	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	55.40	8.01	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.98	5.84	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	190.71	29.47	2.47	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	137.24	9.58	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	35.36	7.48	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	121.28	12.86	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	31.81	6.28	2.51	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	53.69	10.46	1.39	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	47.02	4.86	2.16	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	66.22	4.20	1.26	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	55.67	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.67	7.45	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	55.22	7.31	1.35	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	31.96	6.12	1.59	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.21	3.43	0.65	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	52.31	6.01	0.91	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	39.25	9.55	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	30.02	1.20	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	145.71	17.39	1.31	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	25.86	2.93	1.79	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	55.91	6.17	1.06	1.94
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	39.38	3.52	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.24	3.22	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	44.99	5.46	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	136.23	18.62	1.72	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	156.76	22.76	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	46.12	2.23	1.56	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.56	6.77	2.12	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	47.71	6.88	1.90	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.34	4.29	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	81.25	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.65	6.00	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	38.77	1.35	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.59	9.13	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	3.71	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	55.62	10.97	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.37	4.89	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	30.07	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	49.75	2.71	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	5.29	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	4.65	1.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.79	4.46	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	38.67	3.45	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	62.30	5.75	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.07	3.76	1.11	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	28.46	6.10	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	34.75	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.45	3.15	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.59	1.82	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.06	2.37	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	104.30	14.74	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	85.98	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	52.30	3.98	1.12	0.50
Myoblast, donor2	11322-117D8	63.10	4.60	0.77	1.53
Myoblast, donor3	11398-118D3	66.09	8.91	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	111.64	12.11	0.00	1.17
Natural Killer Cells, donor1	11230-116C6	167.29	16.91	1.23	0.31
Natural Killer Cells, donor2	11311-117C6	118.21	17.79	2.11	1.51
Natural Killer Cells, donor3	11387-118C1	125.89	16.75	1.84	0.55
Neural stem cells, donor1	11275-116H6	182.20	11.25	2.90	0.36
Neural stem cells, donor2	11352-117H2	229.15	13.48	3.85	0.00
Neurons, donor1	11494-119E9	170.68	15.93	1.14	2.28
Neurons, donor2	11574-120E8	175.47	10.57	0.66	0.66
Neurons, donor3	11655-122E8	111.81	9.04	4.11	2.47
Neutrophils, donor1	11233-116C9	100.22	4.64	0.00	0.00
Neutrophils, donor2	11314-117C9	46.38	2.90	0.00	2.90
Neutrophils, donor3	11390-118C4	97.73	4.89	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	104.84	4.04	0.24	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	62.19	0.98	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	60.57	4.21	0.40	1.60
Olfactory epithelial cells, donor1	11933-125I7	39.09	2.75	2.48	0.41
Olfactory epithelial cells, donor2	11934-125I8	50.23	4.05	3.04	0.87
Olfactory epithelial cells, donor3	11935-125I9	43.36	2.95	2.27	0.79
Olfactory epithelial cells, donor4	11936-126A1	48.60	3.60	1.36	1.27
Oligodendrocyte - precursors, donor1	11496-119F2	111.94	5.42	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	54.45	7.44	1.70	0.64
Osteoblast - differentiated, donor2	11353-117H3	38.87	2.29	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	29.79	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	126.25	14.66	0.59	0.98
Osteoblast, donor2	11354-117H4	108.16	25.28	0.70	1.40
Osteoblast, donor3	11426-118G4	86.73	9.06	0.53	1.42
Pancreatic stromal cells, donor1	11249-116E7	84.15	4.63	1.18	0.76
Pericytes, donor1	11491-119E6	40.50	1.89	0.22	0.11
Pericytes, donor2	11571-120E5	43.46	2.72	1.13	0.68
Pericytes, donor3	11652-122E5	51.47	3.87	1.02	0.20
Perineurial Cells, donor1	11499-119F5	85.44	6.89	0.23	0.11
Perineurial Cells, donor2	11579-120F4	99.00	9.75	0.28	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	126.54	3.82	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	74.93	4.65	0.49	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	101.98	3.36	0.78	0.52
Placental Epithelial Cells, donor1	11278-116H9	81.32	5.02	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	52.12	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	62.24	1.77	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	23.10	2.53	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	37.14	3.56	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	104.94	9.27	0.65	0.52
Preadipocyte - breast, donor2	11328-117E5	37.82	4.05	0.45	1.35
Preadipocyte - omental, donor1	11468-119C1	41.45	3.84	1.60	0.43
Preadipocyte - omental, donor2	11329-117E6	49.76	6.11	2.62	0.44
Preadipocyte - omental, donor3	11403-118D8	40.54	4.73	1.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	34.45	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	74.02	7.06	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	84.11	5.14	0.35	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	50.23	4.26	0.68	0.51
Preadipocyte - visceral, donor1	11280-116I2	88.77	6.71	1.30	0.37
Preadipocyte - visceral, donor2	11357-117H7	59.36	9.20	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	62.90	10.34	0.31	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	118.27	6.79	0.15	0.45
Prostate Epithelial Cells, donor2	11331-117E8	43.20	2.71	0.95	1.35
Prostate Epithelial Cells, donor3	11404-118D9	38.15	1.16	0.12	0.18
Prostate Stromal Cells, donor1	11254-116F3	97.84	5.47	0.91	0.80
Prostate Stromal Cells, donor2	11332-117E9	76.74	3.94	0.72	2.69
Prostate Stromal Cells, donor3	11405-118E1	49.43	2.71	0.73	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	81.39	4.38	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	73.75	3.53	0.28	0.42
Renal Epithelial Cells, donor1	11517-119H5	58.33	2.54	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	71.84	7.11	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	79.50	3.81	0.21	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	43.57	7.49	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	70.35	10.92	0.40	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	115.22	10.66	0.67	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.26	2.00	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	84.73	5.72	0.44	0.66
Renal Mesangial Cells, donor2	11598-120H5	64.58	7.52	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	39.67	2.50	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	95.02	4.29	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	47.65	3.80	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	78.49	5.59	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	104.49	12.96	0.78	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	103.46	9.38	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	53.51	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	58.96	2.01	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	68.96	3.88	0.80	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	90.23	8.04	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	177.77	44.03	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	122.97	24.36	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	116.37	11.18	1.69	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	79.05	8.24	1.29	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	98.15	8.14	0.67	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	157.29	13.40	0.50	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	87.76	8.51	0.93	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	107.25	12.02	2.31	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	98.30	13.69	1.92	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	92.28	10.14	0.91	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	75.44	6.09	1.25	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	96.40	14.78	0.86	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	87.14	7.30	1.07	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	90.50	11.73	1.77	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	92.34	20.65	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	85.71	6.61	1.30	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	107.67	8.08	1.13	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	109.35	13.54	1.86	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.94	10.22	1.07	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	100.64	11.84	1.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	100.92	14.20	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	79.89	7.01	0.84	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	89.89	7.01	0.68	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	96.27	16.41	1.64	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	90.50	8.58	0.37	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	92.14	11.01	0.40	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	88.69	19.81	1.42	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	77.58	9.13	1.79	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	98.68	9.59	2.57	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	102.85	13.69	0.83	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.56	9.07	1.11	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	96.30	7.73	2.09	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	104.03	14.80	1.08	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	93.49	9.37	1.87	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	94.66	8.10	0.77	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	112.62	23.38	1.55	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	90.94	7.82	1.51	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	103.10	10.67	1.81	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	107.03	24.54	1.36	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	97.36	13.61	1.48	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	102.62	7.20	0.80	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	110.34	13.96	0.83	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	76.91	9.29	0.24	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	108.23	11.49	1.21	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	98.13	13.18	0.57	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	90.48	8.04	0.35	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	90.97	9.37	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	91.18	12.12	0.73	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	130.42	12.08	1.02	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	85.79	7.91	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	92.53	13.26	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	80.98	10.63	0.68	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	86.57	9.29	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	115.95	9.33	1.89	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	77.69	5.55	0.64	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	65.51	8.41	0.60	3.00
Schwann Cells, donor1	11498-119F4	67.89	9.78	0.38	0.94
Schwann Cells, donor2	11578-120F3	78.26	13.61	0.00	0.00
Schwann Cells, donor3	11659-122F3	89.17	7.23	0.22	1.75
Sebocyte, donor1	11220-116B5	121.06	18.62	1.10	0.00
Sebocyte, donor2	11301-117B5	69.85	13.33	1.38	0.92
Sebocyte, donor3	11378-118B1	58.33	4.74	0.21	1.03
Sertoli Cells, donor1	11255-116F4	64.61	16.57	0.00	0.00
Sertoli Cells, donor2	11333-117F1	33.89	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	103.73	2.82	0.70	0.18
Skeletal Muscle Cells, donor2	11358-117H8	25.30	1.45	0.00	2.17
Skeletal Muscle Cells, donor3	11430-118G8	113.70	16.72	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	78.08	13.67	0.47	1.73
Skeletal Muscle Cells, donor5	11455-119A6	71.94	10.11	0.89	1.49
Skeletal Muscle Cells, donor6	11459-119B1	88.96	14.93	0.46	3.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	95.51	6.43	0.00	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	63.92	5.14	0.14	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	100.40	8.43	0.00	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	104.98	5.98	0.59	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	91.92	9.41	0.00	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	75.82	10.60	0.69	2.61
Skin - palm, donor1	10286-104F7	72.52	8.06	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	38.06	8.51	0.58	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	221.65	33.53	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	34.66	7.53	0.26	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	43.93	2.64	0.97	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	38.96	2.95	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	151.40	19.45	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	41.22	1.27	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	37.96	7.10	0.93	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	74.70	12.67	0.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.19	5.88	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	91.71	3.31	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	68.91	13.39	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	69.53	5.41	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	53.04	3.00	0.00	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	72.79	6.92	1.06	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	46.10	7.09	1.33	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.94	11.39	0.51	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	60.23	5.86	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.33	9.45	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	38.44	3.27	0.14	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	45.55	1.46	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	66.67	3.65	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	64.91	6.06	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	348.88	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	41.96	3.34	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	56.63	3.83	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	50.15	4.30	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	62.97	5.67	0.52	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	85.38	10.98	2.01	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	46.35	5.39	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	62.76	9.26	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	59.40	5.12	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	67.46	2.20	0.08	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	64.31	5.74	2.21	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	52.34	7.05	0.46	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	54.95	12.08	3.02	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	152.60	19.34	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	84.16	11.85	0.67	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.22	5.01	1.13	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	39.57	2.03	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	82.93	7.24	1.21	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	50.26	3.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	334.68	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	80.46	3.26	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.84	6.56	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.31	5.64	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	39.82	2.36	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	133.87	14.16	0.42	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	53.26	1.40	0.00	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	68.22	4.75	0.86	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	82.61	6.88	1.02	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	68.82	9.40	0.56	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	117.80	3.91	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	63.76	3.10	0.34	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.71	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	74.87	6.85	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	68.05	13.48	1.99	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	45.35	3.22	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	44.12	2.92	0.78	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.09	6.88	0.79	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	54.68	13.39	0.37	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	47.79	10.78	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.88	7.38	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	83.89	19.69	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	43.93	7.36	0.00	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	35.94	3.99	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	34.69	3.76	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	53.17	4.58	0.46	0.46
Synoviocyte, donor1	11291-117A4	45.78	2.69	0.50	0.50
Synoviocyte, donor2	11368-117I9	33.69	3.35	0.84	0.50
Synoviocyte, donor3	11440-118H9	27.70	2.01	1.12	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	107.56	14.29	0.71	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	3.96	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	42.84	3.94	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	69.61	3.73	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	37.50	3.48	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	39.51	6.87	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	79.72	4.43	0.86	0.62
Urethra, donor2	10319-105A4	71.94	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	35.86	2.13	0.53	0.00
Urothelial Cells, donor2	11600-120H7	31.24	2.80	0.00	1.20
Urothelial Cells, donor3	11681-122H7	25.67	3.21	0.23	0.23
Urothelial cells, donor0	11216-116B1	59.07	3.57	0.22	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	130.80	8.90	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	160.12	4.29	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	64.34	3.42	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	130.16	4.48	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	98.19	3.49	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	130.16	8.33	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	165.20	6.42	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	79.42	4.56	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	105.60	13.45	1.97	0.99
Wilms' tumor cell line:HFWT	10597-108E3	105.60	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	74.30	12.85	0.84	0.56
achilles tendon, donor2	10292-104G4	109.53	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	120.85	16.57	0.51	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	204.55	24.84	0.46	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	236.23	15.55	0.71	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	178.78	32.93	2.18	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	167.81	42.16	0.84	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	140.21	15.86	1.48	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	164.42	16.88	3.27	3.81
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	127.34	29.96	1.32	3.97
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	155.18	18.78	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	164.25	27.96	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	101.94	16.93	0.18	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	226.23	39.01	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	129.20	35.32	0.70	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	193.40	23.04	2.33	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	163.36	21.04	0.88	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	113.40	8.83	0.46	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	90.89	4.52	0.82	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	93.62	12.89	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	160.44	18.78	0.43	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	136.48	15.47	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	153.81	17.57	1.20	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	117.61	14.48	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	120.74	19.35	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	174.67	26.01	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	157.44	25.99	0.75	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	148.29	27.04	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	179.95	29.99	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	67.12	11.07	3.06	0.00
adipose tissue, adult, pool1	10010-101C1	62.51	3.10	0.62	0.31
adipose, donor1	10184-103D4	436.87	19.35	0.00	8.80
adipose, donor2	10185-103D5	102.19	3.24	1.22	0.41
adipose, donor3	10186-103D6	184.61	5.17	1.09	2.45
adipose, donor4	10187-103D7	448.98	5.20	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	206.27	23.99	3.95	1.10
adrenal gland, adult, pool1	10081-102A9	36.38	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	71.24	12.67	0.40	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	161.50	11.43	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	57.50	2.09	0.93	0.46
amniotic membrane cells, donor2	12236-129G4	98.73	2.03	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	59.21	2.36	0.88	0.29
amygdala - adult, donor10196	10167-103B5	65.22	5.93	0.00	2.37
amygdala, adult, donor10252	10151-102I7	71.98	2.64	1.62	1.62
amygdala, newborn, donor10223	10360-105E9	53.58	4.52	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	121.47	2.42	0.25	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	126.86	22.94	2.21	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	220.80	12.03	1.00	1.00
aorta, adult, pool1	10052-101G7	59.23	1.37	0.98	1.18
appendix, adult	10189-103D9	90.82	3.10	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	121.75	12.73	1.72	1.03
artery, adult	10190-103E1	33.97	2.72	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	209.33	9.56	0.72	0.72
b cell line:RPMI1788	10427-106D4	102.75	6.84	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	48.83	4.16	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	123.94	10.32	0.79	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	44.02	4.18	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	83.89	14.54	1.12	1.68
bladder, adult, pool1	10011-101C2	77.46	0.65	0.33	0.76
blood, adult, pool1	10053-101G8	55.37	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	46.24	4.28	0.86	0.86
bone marrow, adult	10192-103E3	70.18	4.72	2.02	3.37
brain, adult, donor1	10084-102B3	48.18	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	62.25	3.12	0.56	0.11
brain, fetal, pool1	10085-102B4	82.81	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	176.74	6.94	1.32	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	91.74	6.74	1.62	0.37
breast, adult, donor1	10080-102A8	41.04	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	83.46	9.27	1.52	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	106.99	10.20	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	190.85	7.60	0.92	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	68.99	12.35	1.21	0.24
carcinoid cell line:NCI-H1770	10703-109H1	126.95	18.81	0.94	2.82
carcinoid cell line:NCI-H727	10735-110B6	68.25	6.67	0.66	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	106.79	19.96	0.32	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	176.48	14.91	0.53	2.93
caudate nucleus - adult, donor10196	10177-103C6	71.38	9.21	3.45	2.30
caudate nucleus, adult, donor10252	10164-103B2	67.10	1.84	1.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	59.60	4.58	2.29	1.53
caudate nucleus, newborn, donor10223	10354-105E3	63.72	2.93	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	131.10	14.57	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	113.80	2.78	1.28	2.35
cerebellum, adult, pool1	10083-102B2	43.81	3.10	2.76	0.69
cerebellum, newborn, donor10223	10357-105E6	104.62	4.15	4.15	0.00
cerebral meninges, adult	10188-103D8	61.77	1.76	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	50.43	2.19	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	121.35	10.06	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	128.93	11.43	0.66	0.17
cervix, adult, pool1	10013-101C4	105.10	2.73	0.52	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	177.80	10.59	1.11	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	160.69	9.94	0.00	0.99
choriocarcinoma cell line:SCH	10785-110H2	59.63	3.94	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	106.49	4.98	0.47	1.19
chorionic membrane cells, donor1	12238-129G6	45.30	0.57	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	83.82	5.07	0.60	0.80
chorionic membrane cells, donor3	12240-129G8	59.89	2.20	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	137.33	29.28	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	106.61	20.55	0.19	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	92.29	18.16	0.21	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	115.05	4.62	0.51	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	136.66	5.81	0.48	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	130.51	7.74	0.41	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	130.44	9.42	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	146.47	30.75	3.65	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	112.23	8.00	0.69	2.06
clear cell carcinoma cell line:TEN	10636-108I6	98.73	7.29	1.39	1.04
colon carcinoma cell line:CACO-2	10513-107D9	114.40	11.71	0.73	0.18
colon carcinoma cell line:COLO-320	10420-106C6	342.07	19.00	0.00	1.14
colon, adult, donor1	10082-102B1	52.36	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	70.85	1.76	0.59	0.82
colon, fetal, donor1	10070-101I7	55.00	1.85	1.24	2.47
common myeloid progenitor CMP, donor1	12130-128D6	119.17	27.50	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	121.96	12.75	1.27	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	108.67	11.17	0.75	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	139.60	11.70	0.71	0.28
corpus callosum, adult, pool1	10042-101F6	95.75	1.66	1.22	0.11
cruciate ligament, donor2	10295-104G7	106.17	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	60.99	4.82	0.00	0.80
diencephalon, adult	10193-103E4	42.96	2.88	1.20	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	243.85	26.18	1.61	5.28
ductal cell carcinoma cell line:KLM-1	10438-106E6	130.01	10.00	1.03	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	86.18	14.20	0.00	0.72
ductus deferens, adult	10196-103E7	76.25	1.99	0.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	63.37	4.32	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	128.00	5.89	1.47	2.21
dura mater, adult, donor1	10041-101F5	90.19	4.13	1.57	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	107.93	11.99	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	191.44	17.77	2.58	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	63.51	3.70	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	51.76	4.54	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.43	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	78.81	1.31	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	109.27	5.03	2.68	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	130.49	4.53	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	71.24	9.97	4.66	1.61
epidermoid carcinoma cell line:A431	10426-106D3	80.59	6.22	1.11	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	128.24	15.51	0.99	0.33
epididymis, adult	10197-103E8	74.93	3.14	1.26	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	87.46	5.14	0.89	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	54.66	8.65	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	212.69	20.44	6.16	2.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	177.45	18.21	3.35	2.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	213.53	26.10	3.02	3.47
esophagus, adult, pool1	10015-101C6	54.04	2.12	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	183.35	6.14	2.25	0.13
eye - muscle inferior rectus, donor1	10272-104E2	84.51	9.66	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	42.08	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	43.16	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	81.40	2.29	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	4.37	2.91	1.46
eye, fetal, donor1	10054-101G9	81.35	1.53	0.00	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	80.78	9.23	0.90	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	67.90	12.35	0.95	1.42
frontal lobe, adult, pool1	10040-101F4	64.64	2.25	0.66	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	192.46	28.52	4.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	65.74	1.19	0.09	0.00
gall bladder, adult	10198-103E9	63.98	1.21	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	147.10	3.76	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	117.28	3.73	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	88.71	10.14	1.06	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	135.20	5.61	0.97	2.13
gastric cancer cell line:AZ521	10549-107H9	169.04	12.95	4.43	0.82
gastric cancer cell line:GSS	10560-108A2	199.52	14.64	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	105.78	13.94	0.23	2.97
giant cell carcinoma cell line:LU65	10487-107B1	60.35	2.87	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	187.13	7.56	0.28	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	86.55	7.48	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	118.43	9.61	1.06	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	116.42	8.99	1.40	0.28
glioblastoma cell line:T98G	10485-107A8	134.32	4.30	0.33	0.22
glioma cell line:GI-1	10413-106B8	101.04	13.18	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	71.43	5.10	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	90.07	3.17	1.71	0.98
globus pallidus, adult, donor10258	10367-105F7	97.21	4.11	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	53.29	3.20	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	115.02	14.68	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	15.68	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	56.96	8.00	0.96	2.24
hIPS +CCl2, biol_rep1	14383-156B9	178.60	22.50	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	186.56	32.92	0.00	1.83
hIPS +CCl2, biol_rep3	14385-156C2	165.53	18.68	0.00	0.64
hIPS, biol_rep1	14380-156B6	123.61	15.81	0.00	2.87
hIPS, biol_rep2	14381-156B7	133.06	18.52	0.00	0.69
hIPS, biol_rep3	14382-156B8	80.55	7.72	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	114.65	32.18	0.57	1.15
heart - mitral valve, adult	10205-103F7	65.77	2.09	0.00	1.20
heart - pulmonic valve, adult	10206-103F8	51.51	2.61	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	92.42	3.33	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	53.67	6.53	1.02	0.82
heart, adult, diseased, donor1	10051-101G6	57.91	1.70	0.43	1.70
heart, adult, pool1	10016-101C7	39.79	0.92	0.46	0.00
heart, fetal, pool1	10046-101G1	117.26	1.54	0.10	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.63	4.01	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	116.54	10.70	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	121.77	13.26	2.10	1.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	128.90	15.29	1.34	2.67
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	131.07	12.43	2.83	2.73
hepatoma cell line:Li-7	10484-107A7	143.47	6.45	0.89	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	104.52	16.88	0.20	0.50
hippocampus - adult, donor10196	10169-103B7	72.87	4.73	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	72.05	3.47	2.45	1.22
hippocampus, adult, donor10258	10374-105G5	47.80	5.48	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	37.36	4.23	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	305.17	40.28	1.83	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	137.64	11.19	0.00	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	156.40	12.19	0.25	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	152.81	7.89	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	166.03	8.26	0.26	10.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	170.07	11.39	0.38	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	221.59	15.18	0.58	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	162.65	5.39	0.86	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	155.15	9.18	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	171.91	12.08	1.18	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	174.86	8.52	0.64	3.86
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	160.25	14.81	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	135.99	12.05	0.16	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	141.49	23.58	0.98	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	210.33	34.04	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	168.19	6.11	0.00	3.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	136.93	12.21	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	224.39	14.49	0.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	141.86	3.58	0.00	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	133.69	5.91	0.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	142.52	3.45	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	117.90	4.57	1.31	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	126.57	7.55	0.58	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	128.84	4.48	0.60	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	137.08	11.64	0.18	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	141.22	15.41	0.00	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	176.80	35.93	0.00	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	168.65	12.32	0.00	5.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	133.98	7.92	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	129.82	10.29	0.00	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	138.59	7.76	1.03	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	119.55	10.63	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	144.43	7.18	0.00	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	129.36	13.04	2.30	4.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	143.87	8.33	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	117.96	7.73	0.67	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	142.25	17.63	0.00	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	156.43	18.72	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	156.59	21.95	0.00	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	181.54	8.56	0.61	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1015.01	78.08	0.00	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	250.85	17.21	0.00	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	191.55	9.30	0.00	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	157.78	6.51	0.00	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	145.91	6.76	0.36	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	108.60	10.74	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	226.97	8.26	1.63	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	141.16	7.54	0.54	1.35
immature langerhans cells, donor1	11904-125F5	104.37	20.10	2.18	0.48
immature langerhans cells, donor2	11905-125F6	71.29	29.31	2.38	0.79
insula, adult, pool1	10039-101F3	77.03	1.99	0.76	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	82.59	11.71	0.65	0.33
kidney, adult, pool1	10017-101C8	76.50	1.70	1.20	0.70
kidney, fetal, pool1	10045-101F9	142.89	3.47	0.85	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	116.46	5.40	0.99	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	124.42	3.04	0.41	2.76
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	111.75	7.89	0.00	0.18
left atrium, adult, donor1	10079-102A7	47.40	1.63	0.54	2.18
left ventricle, adult, donor1	10078-102A6	27.31	2.53	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	109.99	13.13	2.46	0.27
leiomyoma cell line:10964C	10569-108B2	31.25	7.54	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	36.96	10.87	0.00	0.54
leiomyoma cell line:15425	10571-108B4	41.28	9.47	0.24	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	116.06	13.59	8.36	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	84.65	15.47	0.47	0.47
liposarcoma cell line:KMLS-1	10782-110G8	74.20	3.59	0.62	1.09
liposarcoma cell line:SW 872	10726-110A6	96.98	9.87	0.85	0.49
liver, adult, pool1	10018-101C9	55.75	8.10	1.46	0.32
liver, fetal, pool1	10086-102B5	39.51	1.88	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	58.18	2.33	1.46	0.44
locus coeruleus, adult, donor10252	10165-103B3	59.61	2.03	0.37	0.74
locus coeruleus, adult, donor10258	10375-105G6	46.83	3.39	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	99.69	8.41	2.10	0.00
lung adenocarcinoma cell line:A549	10499-107C4	70.86	1.80	0.97	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	97.90	4.14	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	121.14	6.59	1.71	0.53
lung, adult, pool1	10019-101D1	62.25	1.30	0.12	0.12
lung, fetal, donor1	10068-101I5	188.65	2.57	1.71	1.14
lung, right lower lobe, adult, donor1	10075-102A3	58.19	4.12	1.37	1.37
lymph node, adult, donor1	10077-102A5	56.33	3.31	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	73.86	16.22	0.22	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	135.98	6.94	1.06	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	57.77	7.65	1.70	0.00
mature adipocyte, donor1	12231-129F8	26.64	0.44	0.44	0.00
mature adipocyte, donor2	12232-129F9	28.64	1.25	0.21	0.00
mature adipocyte, donor3	12233-129G1	36.74	1.42	0.24	0.47
mature adipocyte, donor4	12234-129G2	41.33	2.90	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	242.55	17.15	19.54	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	68.81	7.90	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	62.53	3.13	1.84	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	48.92	2.22	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	103.21	5.97	0.43	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	59.23	3.04	2.03	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	70.46	2.55	1.49	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	53.84	5.03	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	70.74	5.19	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	75.39	2.01	0.77	0.77
medulla oblongata, adult, pool1	10038-101F2	76.40	2.69	0.65	0.16
medulla oblongata, newborn, donor10223	10361-105F1	54.51	4.51	2.08	1.74
medulloblastoma cell line:D283 Med	10838-111E1	296.25	14.61	0.22	4.87
medulloblastoma cell line:ONS-76	10759-110E3	79.84	16.51	0.86	0.12
melanoma cell line:COLO 679	10514-107E1	74.17	6.18	1.44	0.29
melanoma cell line:G-361	10465-106H6	98.27	8.14	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	86.83	3.08	0.36	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	213.24	15.86	1.76	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	228.89	19.70	3.11	4.41
mesenchymal precursor cell - adipose, donor1	11747-123G1	74.72	6.90	0.92	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	49.63	5.82	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.48	7.87	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	44.39	4.92	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	44.68	4.24	0.77	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.23	4.16	0.69	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	33.47	3.09	0.17	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	40.14	6.56	0.46	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	65.79	11.27	0.93	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	79.27	14.45	1.22	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	81.23	7.82	1.00	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	40.84	5.60	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	64.48	7.33	0.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	38.05	4.54	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	47.37	3.88	0.20	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	56.07	3.24	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	35.17	1.24	0.00	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	30.78	7.30	0.46	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	120.83	22.24	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	66.05	8.82	0.45	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	54.44	3.68	0.44	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	50.44	2.21	0.74	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	49.51	6.01	0.00	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	99.78	18.52	0.00	6.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.47	5.94	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	50.39	3.84	0.26	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	53.66	4.19	1.31	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	44.98	2.77	1.23	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	45.89	3.29	0.71	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	55.85	4.40	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.12	4.32	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	50.51	2.32	0.93	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.38	3.17	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	46.40	3.35	0.89	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	50.23	1.68	0.72	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.07	5.87	1.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	43.97	3.02	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	46.26	4.09	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	48.11	2.58	2.15	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.72	4.55	0.97	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	46.56	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	40.51	4.80	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.89	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.48	4.66	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	8.39	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	39.74	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	45.66	6.52	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	0.00	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	42.44	3.80	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.39	4.48	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	8.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	7.98	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.49	4.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	4.77	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	30.07	1.18	0.00	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	34.60	0.94	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	39.03	4.73	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	2.57	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	41.99	4.13	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	4.95	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	4.49	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	49.61	7.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	41.51	3.63	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	43.08	6.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	4.25	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	9.04	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.06	3.29	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	36.71	2.58	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	39.59	4.87	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	4.07	2.04	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	39.46	4.64	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	90.95	2.60	1.18	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	104.48	15.99	1.39	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	102.57	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	86.31	9.97	0.72	0.92
mesothelioma cell line:Mero-25	10850-111F4	108.26	11.12	0.00	0.91
mesothelioma cell line:Mero-41	10851-111F5	143.26	7.82	2.44	1.96
mesothelioma cell line:Mero-48a	10852-111F6	104.07	10.85	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	70.17	9.99	0.53	2.37
mesothelioma cell line:Mero-83	10854-111F8	78.81	22.98	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	85.94	8.59	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	80.33	10.77	0.62	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	101.38	9.44	0.83	1.33
mesothelioma cell line:NCI-H226	10846-111E9	87.60	25.34	0.90	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	92.76	14.01	1.20	1.02
mesothelioma cell line:NCI-H28	10845-111E8	104.84	9.92	0.51	1.02
mesothelioma cell line:No36	10857-111G2	87.42	11.42	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	79.93	13.82	0.54	1.08
migratory langerhans cells, donor1	11901-125F2	164.29	7.10	0.38	1.15
migratory langerhans cells, donor2	11902-125F3	93.05	3.05	0.24	0.61
migratory langerhans cells, donor3	11903-125F4	107.69	5.38	0.72	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	110.68	3.26	0.98	4.24
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	53.62	6.57	1.48	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	109.65	8.52	0.92	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	69.84	9.32	0.38	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	193.48	16.45	0.55	3.14
myeloma cell line:PCM6	10474-106I6	65.03	5.73	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	114.14	13.19	1.52	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.07	4.51	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	46.13	1.34	0.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	44.86	1.62	0.00	0.37
nasal epithelial cells, donor2	12227-129F4	128.06	3.86	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	213.96	3.91	0.46	0.23
neuroblastoma cell line:NB-1	10539-107G8	212.15	12.35	0.56	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	224.81	16.45	1.69	2.53
neuroblastoma cell line:NH-12	10555-107I6	215.42	8.01	0.37	3.35
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	125.02	4.03	1.19	3.80
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	182.14	9.82	0.48	3.01
neuroectodermal tumor cell line:TASK1	10774-110F9	190.19	24.96	1.01	2.42
neuroepithelioma cell line:SK-N-MC	10728-110A8	150.68	14.62	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	44.72	6.92	0.80	0.80
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	319.98	11.33	0.00	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	82.45	4.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	67.97	6.09	1.60	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	51.24	4.47	1.05	1.58
nucleus accumbens, adult, pool1	10037-101F1	71.99	2.25	0.94	0.09
occipital cortex - adult, donor10196	10172-103C1	94.78	8.24	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	81.05	3.49	1.34	1.07
occipital cortex, newborn, donor10223	10355-105E4	51.32	2.91	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	59.04	3.94	0.79	1.84
occipital lobe, fetal, donor1	10073-102A1	140.32	10.73	2.15	6.44
occipital pole, adult, pool1	10036-101E9	66.54	1.66	1.02	0.16
olfactory region, adult	10195-103E6	57.51	3.63	1.15	1.53
optic nerve, donor1	10277-104E7	62.03	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	67.21	4.44	1.03	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	67.18	2.89	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	76.87	6.77	1.02	2.54
oral squamous cell carcinoma cell line:SAS	10544-107H4	55.56	2.54	0.12	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	46.15	2.65	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	185.93	9.34	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	169.44	16.12	1.91	0.64
ovary, adult, pool1	10020-101D2	121.33	3.84	0.61	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	62.33	5.87	0.00	0.73
pancreas, adult, donor1	10049-101G4	48.91	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	121.60	8.11	1.40	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	103.06	13.12	0.17	3.75
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	163.43	6.95	0.83	0.50
paracentral gyrus, adult, pool1	10035-101E8	59.95	2.20	0.55	0.37
parietal cortex, adult, donor10258	10373-105G4	144.60	6.61	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	71.48	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	64.70	2.57	1.14	1.14
parietal lobe, adult, pool1	10034-101E7	67.68	1.85	0.62	0.26
parietal lobe, fetal, donor1	10072-101I9	151.29	13.58	5.82	3.88
parietal lobe, newborn, donor10223	10356-105E5	55.71	4.49	2.99	0.37
parotid gland, adult	10199-103F1	64.13	0.62	1.85	0.62
penis, adult	10200-103F2	70.90	1.07	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	77.54	2.60	0.19	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	49.24	4.08	0.87	0.44
pineal gland - adult, donor10196	10179-103C8	129.01	8.39	2.58	0.65
pineal gland, adult, donor10252	10160-103A7	162.86	7.11	2.96	0.59
pineal gland, adult, donor10258	10377-105G8	112.25	10.03	0.63	1.88
pituitary gland - adult, donor10196	10180-103C9	128.50	6.07	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	181.37	6.78	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	100.45	5.11	3.40	0.85
placenta, adult, pool1	10021-101D3	73.42	1.83	1.08	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	128.06	6.22	0.13	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	100.23	5.45	1.25	0.78
pons, adult, pool1	10033-101E6	56.46	1.81	0.69	0.09
postcentral gyrus, adult, pool1	10032-101E5	65.21	2.44	0.70	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	66.13	9.61	0.15	0.87
prostate cancer cell line:PC-3	10439-106E7	123.06	15.97	4.36	0.36
prostate, adult, pool1	10022-101D4	79.36	1.36	0.91	0.18
putamen, adult, donor10196	10176-103C5	70.58	3.54	1.18	1.42
putamen, adult, donor10252	10152-102I8	70.59	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	66.66	8.74	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	51.22	3.62	1.21	0.72
putamen, newborn, donor10223	10365-105F5	119.20	3.00	3.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	90.48	4.07	0.87	0.00
rectum, fetal, donor1	10067-101I4	129.36	1.39	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.16	2.76	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	85.33	3.31	0.41	0.00
retina, adult, pool1	10030-101E3	104.07	0.80	1.29	0.10
retinoblastoma cell line:Y79	10475-106I7	227.85	5.98	1.04	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	85.20	11.43	1.23	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	170.13	10.12	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	57.60	2.27	0.76	0.00
salivary acinar cells, donor1	11771-123I7	57.94	4.05	0.97	0.32
salivary acinar cells, donor2	11772-123I8	71.32	4.96	0.28	0.28
salivary acinar cells, donor3	11773-123I9	43.70	2.65	0.00	0.00
salivary gland, adult, pool1	10093-102C3	71.49	6.29	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	116.52	5.14	1.43	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	106.03	4.70	0.71	0.24
seminal vesicle, adult	10201-103F3	79.36	1.59	2.12	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	103.97	9.23	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	127.07	6.29	2.01	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	190.67	26.09	1.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	101.28	8.06	0.40	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	116.39	8.18	0.33	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	102.70	12.64	1.16	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	66.68	3.55	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	50.49	2.40	0.12	0.60
skeletal muscle, fetal, donor1	10066-101I3	76.38	6.03	0.00	4.02
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	104.78	8.21	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	212.79	18.01	4.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	195.11	24.90	1.89	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	304.16	19.85	0.58	2.89
small cell lung carcinoma cell line:LK-2	10541-107H1	147.52	7.75	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	481.10	11.58	0.00	2.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	197.87	21.36	2.40	0.65
small intestine, adult, pool1	10024-101D6	82.30	2.15	0.36	0.36
small intestine, fetal, donor1	10064-101I1	84.77	6.88	0.98	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	106.17	20.00	1.54	3.59
smooth muscle, adult, pool1	10048-101G3	60.74	1.81	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	77.46	5.63	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	70.89	2.98	2.29	1.38
spinal cord, adult, donor10252	10159-103A6	100.14	3.94	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	89.24	5.53	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	76.84	3.05	3.05	3.05
spinal cord, newborn, donor10223	10359-105E8	104.70	5.97	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	53.77	4.48	0.60	0.30
spleen, adult, pool1	10025-101D7	82.60	2.64	0.55	0.44
spleen, fetal, pool1	10044-101F8	134.99	5.48	0.95	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	108.07	10.45	1.24	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	80.51	3.80	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	70.94	7.34	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	66.46	5.08	1.17	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	149.03	6.87	0.90	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	182.57	18.21	2.12	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	152.31	16.08	2.12	0.00
stomach, fetal, donor1	10062-101H8	119.61	7.48	2.14	1.07
submaxillary gland, adult	10202-103F4	62.10	3.99	0.57	2.28
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	66.47	2.91	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	60.00	5.17	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	46.63	1.41	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	273.97	28.20	5.04	1.60
temporal lobe, adult, pool1	10031-101E4	64.76	1.70	0.76	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	163.11	6.41	4.27	4.99
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	145.93	6.15	0.88	5.27
tenocyte, donor1	11763-123H8	58.30	5.93	2.09	1.40
tenocyte, donor2	11765-123I1	36.62	1.91	0.00	0.76
tenocyte, donor3	11768-123I4	41.51	2.59	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	414.53	33.99	0.85	3.57
teratocarcinoma cell line:NCR-G1	10798-110I6	171.88	14.80	0.62	3.70
teratocarcinoma cell line:PA-1	10807-111A6	132.82	11.00	0.00	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	126.95	19.17	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	297.24	13.24	0.76	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	294.03	33.70	0.76	2.62
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	211.71	21.17	0.65	7.49
testis, adult, pool1	10026-101D8	78.81	3.11	3.76	0.64
testis, adult, pool2	10096-102C6	94.73	7.22	4.06	4.51
thalamus - adult, donor10196	10168-103B6	72.86	6.62	3.31	0.00
thalamus, adult, donor10252	10154-103A1	72.05	1.25	1.25	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.10	2.64	1.15	0.82
thalamus, newborn, donor10223	10366-105F6	65.01	6.33	0.00	0.58
throat, adult	10209-103G2	65.16	3.25	1.50	1.75
throat, fetal, donor1	10061-101H7	111.52	8.84	1.83	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	119.24	10.73	2.19	0.99
thymus, adult, pool1	10027-101D9	201.12	4.77	0.40	0.60
thymus, fetal, pool1	10043-101F7	188.07	5.40	0.31	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	78.05	4.92	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	97.08	8.66	0.14	0.98
thyroid, adult, pool1	10028-101E1	110.76	1.40	0.65	0.37
thyroid, fetal, donor1	10060-101H6	83.58	3.69	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	0.00	0.00	3.08
tongue, adult	10203-103F5	61.63	3.02	0.00	2.56
tongue, fetal, donor1	10059-101H5	58.33	6.31	0.00	1.58
tonsil, adult, pool1	10047-101G2	125.12	3.81	1.70	0.10
trachea, adult, pool1	10029-101E2	72.96	2.04	1.15	0.65
trachea, fetal, donor1	10058-101H4	70.40	4.62	1.54	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	75.81	8.86	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	173.45	13.98	1.82	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	78.19	3.45	0.31	0.78
tridermal teratoma cell line:HGRT	10694-109G1	83.71	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	54.60	3.13	0.51	0.17
umbilical cord, fetal, donor1	10057-101H3	56.34	4.17	0.00	2.09
uterus, adult, pool1	10100-102D1	127.63	2.56	1.02	0.34
uterus, fetal, donor1	10055-101H1	121.84	6.66	0.51	2.56
vagina, adult	10204-103F6	51.70	0.65	0.65	0.65
vein, adult	10191-103E2	84.61	2.85	0.00	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	58.75	4.27	0.00	0.27